Steps in this run
| Step |
Calls |
Tokens in |
Cache hit |
Cost |
|
ranking
|
2 |
127,153 |
|
$0.76464 |
|
response generation
|
3 |
6,711 |
|
$0.03315 |
|
learning engine pattern analysis
|
1 |
13,556 |
|
$0.01504 |
|
haiku prescreen
|
2 |
10,158 |
|
$0.01154 |
|
learning engine self eval
|
1 |
4,618 |
|
$0.00869 |
All 9 API calls — tap to expand
$0.009411
Est. cost (USD)
Result preview
```json
[
{
"post_index": 3,
"cluster_ids": [1, 23],
"claim": "AI second opinions lack rigorous prospective trials in real clinical workflows",
"argument_type": "question_or_critique",
"stance": "challenges_status_quo",
"hyde_excerpt": "Clinical validation of AI diagnostic assistance remains fundamentally incomplete. While observational studies suggest potential utility,
84,065
Tokens in (billed)
$0.470629
Est. cost (USD)
Result preview
```json
[
{
"post_index": 7,
"matched_article_id": 253,
"match_confidence": 88,
"match_reason": "The tweet argues that using outdated AI models instead of current SOTA constitutes clinical malpractice — directly engaging the article's central thesis that AI diagnostic superiority creates legal duty for physicians to adopt available AI tools, with the tweet explicitly claiming 'no
$0.010560
Est. cost (USD)
Result preview
The malpractice argument actually gets sharper when you follow the FDA approval mechanism. Once an adaptive AI algorithm clears FDA review, it doesn't stay optional for long. That regulatory stamp is precisely what courts and expert witnesses use to establish what's "standard in the field," and that's the moment physician non-adoption stops being conservative judgment and starts looking like a bre
$0.012135
Est. cost (USD)
Result preview
The prospective trial gap is real, but there's a subtler problem that tends to get skipped in this conversation: even when rigorous trials do exist, the findings don't always point where people expect them to.
The DeepSeek-R1 RCT I wrote about recently randomized 32 critical care residents across six hospitals on diagnostically challenging cases. The AI alone hit 60 percent top-1 accuracy, reside
$0.010458
Est. cost (USD)
Result preview
The question this raises for anyone paying for these drugs at scale: if the clinical benefit timeline is months to years, but only 1-in-12 patients remain on therapy after three years, who actually captures the return on that investment?
That persistence gap is the center of gravity for every employer coverage decision right now. And 59% of large employers are already reporting higher-than-expect
$0.002126
Est. cost (USD)
Result preview
```json
[]
```
39,732
Tokens in (billed)
$0.294012
Est. cost (USD)
Result preview
[]
$0.008686
Est. cost (USD)
Result preview
```json
[
{"post_index": 0, "prediction": "reject", "confidence": 95, "reason": "Off-topic (military/drones), not healthcare-related"},
{"post_index": 1, "prediction": "reject", "confidence": 95, "reason": "Off-topic (sports/horses), not healthcare-related"},
{"post_index": 2, "prediction": "r
13,556
Tokens in (billed)
$0.015041
Est. cost (USD)
Result preview
```json
[
{
"category": "ai_safety_vulnerability_incident_tangential",
"summary": "Posts about AI agent security breaches, hacks, or safety vulnerabilities without healthcare system application context.",
"exclusion_rule": "Exclude posts that report AI safety incidents, security vulner